Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Has right and left hands with a rating of 3 or 4 on the Busso Hand Volume Severity Scale (BHVSS) as determined by the treating physician~* Signs a written informed consent~* Understands and accepts the obligation not to receive any other procedures in the dorsum of the hands through 12 month follow up~* Understands and accepts the obligation and is logistically able to present for all scheduled follow-up visits~Exclusion Criteria~* Has history of hypertropic scarring~* Has a known bleeding disorder or receiving medication that will increase the risk of bleeding as the result of injection~* Has a known hypersensitivity to any of the components of Radiesse or local anesthesia~* Has used predefined products or treatments on the dorsum of the hand within last 4 weeks or intends to use during study~* Has had any dermal fillers or surgery in the dorsum of the hand~* Is a female of child bearing potential and not using medically effective birth control or is pregnant or lactating

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Radiesse Injectable Dermal Filler (Type: EXPERIMENTAL): Device: Radiesse Injectable Dermal Filler
- Delayed Treatment (Type: ACTIVE_COMPARATOR): Cross over to treatment with Radiesse Injectable Dermal Filler at 3 Months

Based on this trial design, predict the completion outcome and termination type (if applicable).